56 completed, 39 recruiting, 15 terminated, 15 unknown. 42 Not applicable, 36 Phase 1, 36 Phase 2, 4 Phase 3, 2 Phase 4.
Follow Renal Cancer: new trials by email Literature Review of Renal Cancer trials Research Report on Renal Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Comparing Single-Port and Multi-Port Robot-Assisted Surgery in Patients With Prostate or Kidney (Renal) Cancer Prostate Cancer, Renal Cancer | Not yet recruiting | IRCCS San Raffaele | 376 | 2026-10-01 | 2026-09-15 | |
| SL-28 for Advanced Solid Tumours SL-28 - Head & Neck Cancer, Pancreas Carcinoma | Phase 1 / Phase 2 | Recruiting | Second Life Therapeutics | 60 | 2026-08-14 | 2026-09-15 |
| Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance Liver Cancer (Primary and Metastatic), Lung Cancer (Diagnosis) | Recruiting | Mark C Burgmans, MD PhD | 2000 | 2026-07-01 | 2026-09-01 | |
| Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer PF-08634404, Ipilimumab, Axitinib - Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma | Phase 1 / Phase 2 | Recruiting | Pfizer | 224 | 2026-02-10 | 2026-10-08 |
| Stereotactic Body RadioTherapy With Continuous Tracking for Primary and Secondary Renal Cancer Stereotactic body radiotherapy (SBRT) - Renal Cancer, Renal Secondary Cancer | Not applicable | Not yet recruiting | IRCCS San Raffaele | 60 | 2026-01-15 | 2025-12-16 |
| Prospective Observational Trial of Image-guided Ablative STereotactic bOdy Radiation Therapy for Primary kidNey Cancer: the STONE Trial Stereotactic body radiotherapy (SBRT) - Renal Cancer | Recruiting | Istituto Clinico Humanitas | 53 | 2026-01-01 | 2026-01-21 | |
| Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed? investigation setting (cystoscopy + CTU + cytology), Cystoscopy - CTU - cytology (if needed) - Hematuria, Acute Cystitis With Hematuria | Recruiting | Vastra Gotaland Region | 300 | 2025-10-13 | 2025-11-21 | |
| A Study of BL-B01D1+TKI±Pembrolizumab in Patients With Locally Advanced or Metastatic Renal Cancer BL-B01D1, Axitinib, Lenvatinib - Renal Cancer | Phase 2 | Recruiting | Sichuan Baili Pharmaceutical Co., Ltd. | 260 | 2025-07-28 | 2025-11-17 |
| Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers For each enrolled patient, the sample described below will be collected as specific intervention intended for research purposes: - Urothelial Carcinoma, Renal Cancer | Not applicable | Recruiting | Institut Claudius Regaud | 450 | 2025-07-23 | 2026-06-15 |
| Occupational Situation and Return to Work of Urological Patients Occupational Status Survey and Telephone Follow-up and Quality-of-Life Assessment in a subset of patients - Bladder Cancer, Prostate Cancer | Recruiting | Jagiellonian University | 2000 | 2025-07-21 | 2026-03-03 | |
| Head-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pathologist-Only Review Digital Pathology Evaluation - Brain Cancer, Lung Cancer (Diagnosis) | Enrolling by invitation | Harvard Medical School (HMS and HSDM) | 30 | 2025-06-12 | 2025-12-29 | |
| Application of the "Off-Clamp And Sutureless" Technique in Robot-Assisted Partial Nephrectomy Off-Clamp Sutureless Technique - Renal and Urinary Disorders, Renal Cancer | Not applicable | Recruiting | Shao Pengfei | 190 | 2025-06-01 | 2025-09-05 |
| Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study) Irreversible electroporation - Colorectal Carcinoma, Renal Cancer | Recruiting | Amsterdam UMC, location VUmc | 27 | 2025-04-18 | 2026-08-28 | |
| Comparison Between HUGO RAS Robotic Platform and Da Vinci Robotic Platform Radical prostatectomy, Partial nephrectomy - Prostate Cancer (Adenocarcinoma), Renal Cancer | Not applicable | Not yet recruiting | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 800 | 2025-03-31 | 2025-02-25 |
| Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology Liver Cancer (Primary and Metastatic), Renal Cancer | Recruiting | Palo Alto Veterans Institute for Research | 30 | 2025-02-01 | 2025-12-26 | |
| Prehabilitation Prior to Surgery for Kidney Tumors Prehabilitation - Renal Cancer, Renal Cell Cancer | Not applicable | Active not recruiting | Herlev and Gentofte Hospital | 60 | 2025-01-21 | 2026-09-02 |
| Comparison Between Epidural Analgesia and Intrathecal Opioid Analgesia for Pain Management in Open Nephrectomy Epidural analgesia, Intrathecal opioid analgesia - Pain, Renal Cancer | Phase 1 | Recruiting | University Hospital of Split | 40 | 2025-01-15 | 2025-03-10 |
| CD70-targeted immunoPET Imaging of Malignant Cancers [18F]F-RESCA-RCCB6, [18F]F-RESCA-R8B4, [68Ga]Ga-NOTA-R8B4 - Renal Cancer, Renal Clear Cell Carcinoma | Phase 2 | Recruiting | RenJi Hospital | 300 | 2024-12-23 | 2026-05-12 |
| Renal Tumour Imaging Using MRI MRI - Renal Cancer, MRI | Not applicable | Active not recruiting | University College, London | 30 | 2024-11-20 | 2025-09-15 |
| A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Colorectal, Ovarian, and Renal Cancers AUR109 200mg, AUR109 300mg, AUR109 400mg - Ovarian Cancer, Colorectal Cancer | Phase 2 | Terminated | Aurigene Discovery Technologies Limited | 29 | 2024-11-09 | 2026-04-17 |
Showing 20 of 148. Sign in to see all of them.
Kidney Neoplasms (148) · Prostatic Neoplasms (28) · Carcinoma, Renal Cell (26) · Lung Neoplasms (24) · Urinary Bladder Neoplasms (24) · Breast Neoplasms (20) · Melanoma (19) · Neoplasms (18) · Pancreatic Neoplasms (18) · Ovarian Neoplasms (15) · Colorectal Neoplasms (13) · Neoplasm Metastasis (13) · Carcinoma, Non-Small-Cell Lung (12) · Stomach Neoplasms (11) · Head and Neck Neoplasms (10)
Female Urogenital Diseases (148) · Female Urogenital Diseases and Pregnancy Complications (148) · Male Urogenital Diseases (148) · Urogenital Diseases (148) · Neoplasms by Site (147) · Urogenital Neoplasms (147) · Kidney Diseases (146) · Urologic Neoplasms (144) · Urologic Diseases (143) · Neoplasms (130) · Neoplasms by Histologic Type (64) · Neoplasms, Glandular and Epithelial (45) · Genital Diseases (38) · Carcinoma (36) · Lung Diseases (33)
Nivolumab (7) · pembrolizumab (6) · Cyclophosphamide (5) · Ipilimumab (5) · Radiosurgery (5) · aldesleukin (5) · atezolizumab (5) · Blood Specimen Collection (4) · fludarabine (4) · Axitinib (3) · Bevacizumab (3) · Sorafenib (3) · durvalumab (3) · fludarabine phosphate (3) · Everolimus (2)
Memorial Sloan Kettering Cancer Center (11) · National Cancer Institute (NCI) (10) · Amgen (3) · Beth Israel Deaconess Medical Center (3) · Bristol-Myers Squibb (3) · Hospices Civils de Lyon (3) · IRCCS San Raffaele (3) · Ludwig Institute for Cancer Research (3) · Pfizer (3) · Samsun Liv Hospital (3) · AEterna Zentaris (2) · Dana-Farber Cancer Institute (2) · Duke University (2) · GlaxoSmithKline (2) · HistoSonics, Inc. (2)
United States (64) · France (16) · United Kingdom (14) · Italy (12) · China (10) · Netherlands (8) · Germany (7) · Canada (6) · Denmark (6) · Belgium (5) · Poland (5) · Spain (5) · Australia (4) · Japan (4) · Sweden (3)
Steven A Rosenberg, M.D. (3) · Ender Ozden, Prof. (2) · W. Marston Linehan, M.D. (2) · Adriaan Bins, MD, PhD (1) · Albert Dahan, MD (1) · Alexander Prokhorov, Dr (1) · Ana Molina, MD (1) · Andrei Hancharou (1) · Antonino Agrusa, Medicine (1) · Arduino A Mangoni, MD, PhD (1) · Arnulf Stenzl, MD, Prof (1)
PMID 33931361, PMID 17395103, PMID 18632142, PMID 21633906, PMID 21917625, PMID 23731770, PMID 23937616, PMID 23990665, PMID 24013181, PMID 24327518, PMID 24598448, PMID 25225420, PMID 25379846, PMID 26251228, PMID 26631616, PMID 27154574, PMID 27286790, PMID 27424289, PMID 27614693, PMID 27959744, PMID 27988238, PMID 28053024, PMID 28237280, PMID 28597328, PMID 28672195, PMID 28822586, PMID 29185869, PMID 29266183, PMID 29383130, PMID 29478736, PMID 29846250, PMID 29853306, PMID 30243799, PMID 30321406, PMID 30352550, PMID 30367117, PMID 30405781, PMID 30717745, PMID 30832732, PMID 30975030, PMID 31101621, PMID 31243370, PMID 31271825, PMID 31401903, PMID 31533931, PMID 31677114, PMID 31831767, PMID 31882719, PMID 31894292, PMID 31898992
2016 (1), 2017 (1), 2023 (1), 2025 (1), R01CA229354 (1), R01CA258297 (1), R01HG011928 (1)